Special Interests

Research Interests

Mechanisms responsible for the initiation and progression of lung fibrosis. Lung disease in patients with autoimmune disorders such as rheumatoid arthritis and scleroderma, among others.

Education

Education

University of Minnesota Medical School, Medical School

Internships

Presbyterian Hospital, Pacific Presbyterian Medical Center, Medical Internship

Residency

Providence Medical Center, Chief Medical Resident

Providence Medical Center, Medical Residency

Fellowship

Maine Medical Center, Pulmonary/ CCM Fellowship

National Jewish Health/University of Colorado Health Sciences Center, Pulmonary/CCM, Research Fellowship

Awards & Recognition

2001-2016: America's Top Doctors
2002-2016: Best Doctors in America
2004-2005: America's Top Physicians
2002: Clinician of the Year, National Jewish Health

Board Certification

Internal Medicine Pulmonary

Publications

Raghu G, Brown KK, Bradford WZ, Starko K, Noble PW, Schwartz DA, King TE A Randomized, Double-Blind, Placebo-Controlled Trial of Recombinant Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis. N Engl J Med 2004 Jan 8; 350:125-33.

Vourlekis JS, Schwarz MI, Cherniack RM, Curran-Everett D, Cool CD, Tuder RM, Lynch DA, King TE, Brown KK. The Impact of Pulmonary Fibrosis on Survival in Hypersensitivity Pneumonitis. Am J Med. 2004 May 15;116(10):662-8.

Collard HR, King TE, Bucher-Bartleson B, Vourlekis JV, Schwarz MI, Brown KK. Changes in clinical and physiologic variables predict survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2003 Sep 1;168(5):538-42.

SurattBT, Cool CD, Serls A,Varella-Garcia M, Shpall EJ, Brown KK, Worthen GS. Human Pulmonary Microchimerism Following Hematopoietic Stem Cell Transplantation Am J Respir Crit Care Med. 2003 Aug 1;168(3):318-22.

Academic Affiliations

Professor, University of Colorado, Denver School of Medicine